@article {321, title = {Research Policy of the Investigational Drugs in the Clinical Trial}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {03-08}, type = {Review Article}, chapter = {03}, abstract = {

Objectives: This study aims to explore the research policy of investigational drugs in the clinical trial as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term encompasses all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes the research policy for investigational drugs in the clinical trial. Results: A general policy was established for investigational drugs in clinical trials, which included defining clinical trials and addressing related issues. Clinical trial approval policy, the role of the Institutional Review Board, the clinical responsibilities of the research team, and patient informed consent. Apart from that, clinical trials require patient records and auditing. Conclusion: The research policy for investigational drugs in a clinical trial is a novel initiative within pharmaceutical care research and development. The research policy for investigational drug in clinical trials protects patient rights and safety. Additionally, encourage pharmacy services to implement and conduct clinical trials in pharmacy practice at healthcare institutions of Saudi Arabia.

}, keywords = {Clinical trial, Drug, Investigational, Policy, Research, Saudi Arabia}, doi = {10.5530/ijpcs.2022.11.2}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha HusseinAlmadany and Abeer Hussin Almasoudi} } @article {322, title = {Research Policy on Pharmacy Investigational Medication}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {11}, year = {2022}, month = {April 2022}, pages = {09-14}, type = {Review Article}, chapter = {09}, abstract = {

Objectives: This study aims to demonstrate the Research Policy of Pharmacy Investigational Medication as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Litterateur researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The time period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompasses narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital settings. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists specializing in drug information, and clinical research specialists. A member drafted the policy{\textquoteright}s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The subject emphasizes Pharmacy Research{\textquoteright}s policy on Investigational Medication. Results: The Pharmacy Research policy for Investigational Medication consisted of a number of components, including the administration of pharmacies, the procurement of investigational drugs, and the storage of investigational drugs. Additionally, the investigative drug prescription, the preparation of investigative drugs, the dispensing of investigative drugs, the administration of investigative drugs, and the monitoring of investigative drugs. There were a number of essential policy items, including the safety of investigational medications, the cost of investigational drugs, and the sponsors of investigational drug research. Conclusion: The Pharmacy Research policy for Investigational Medication is a new initiative as part of pharmacy practice research and development. Investigational Medication Pharmacy Research policy helps healthcare organizations improve patient safety and prevent drug-related morbidity and mortality. It is a component of Saudi Arabia{\textquoteright}s pharmacy strategic plan for Vision 2030 and pharmacy reimbursement initiatives.

}, keywords = {Drug, Investigational, Medication, Pharmacy, Policy, Research, Saudi Arabia}, doi = {10.5530/ijpcs.2022.11.3}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Hamidah Qasim Ali Abushomi and Maha Hussein Almadany and Abeer Hussin Almasoudi} } @article {242, title = {Antibiotics Therapeutic Interchanges: A Narrative Reviews}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {9}, year = {2020}, month = {February 2020}, pages = {14-19}, type = {Review Article }, chapter = {14}, abstract = {

Objective: To review the antibiotics therapeutic interchanges. Methods: It is an extensive search, or fifty databases included the following through the Saudi Digital Library (SDL) searching engine. It included the various type of studies (meta-analysis, randomized controlled studies and observational studies) in the English language with human study only for the update May 2017. The search in terms of therapeutic interchange, medication, therapy and type of disease or medication base on therapeutics class of anti-psychiatric. The medication list and switch from one drug to substitute based on the literature found the search that has included comparative safety, efficacy and cost of the type of medication for each disease and national or international evidence-based guidelines. Results: The total number of studies after an extensive search with a specific term search was 487 studies. Of those, there were 107 duplicated studies, and 380 studies included for future evaluation. After evaluation, there were 27 studies discussed the therapeutic interchange of antibiotics. Of those 27 studies, eight studies included for evaluation. Conclusion: Antibiotics therapeutic interchange system properly applicable implementation in practice. Further studies mandate to validate antibiotic therapeutic interchange. Antibiotic therapeutic interchange is highly recommended in the Kingdom of Saudi Arabia.

}, keywords = {Antibiotics, Drug, Literature, Review, Therapeutic interchanges, Therapy}, doi = {10.5530/ijpcs.2020.9.4}, author = {Yousef Ahmed Alomi and Faiz Abdullah Bahadig} } @article {243, title = {Asthma Disorders Therapeutic Interchanges Drug : A Narrative Reviews}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {9}, year = {2020}, month = {August 2020}, pages = {94-97}, type = {Review Article}, chapter = {94}, abstract = {

Objective: To analysis the anti-asthmatic medications therapeutic interchanges drug therapy. Methods: It is an extensive search, or fifty databases comprised the following through the Saudi Digital Library (SDL) searching engine. It encompassed the various types of studies (meta-analysis, randomized controlled studies and observational studies) in the English language with human study only for the update May 2017. The search in terms of therapeutic interchange, medication, therapy and type of disease or medication base on therapeutics class of Anti-psychiatric. The medication list and switch from one drug to another based on the literature found the search that has included comparative safety, efficacy and cost of the type of medication for each disease and national or international evidence-based guidelines. Results: The total number of studies after an extensive search with a specific term search was 487 studies. Of those, there were 107 duplicated studies, and 380 studies included for future assessment. After assessment, there were 14 studies about therapeutic interchange of medicines for asthma. Of those 14 studies, one study included for evaluation. Conclusion: Anti-asthmatic therapeutic interchange studies are occasionally finding in the literature. International asthma management guidelines as an alternative interchange of this matter. Further studies claim to standardized anti-asthmatic therapeutic interchange pharmacy field.

}, keywords = {Asthma, Drug, Literature, Review, Therapeutic interchanges, Therapy}, doi = {10.5530/ijpcs.2020.9.18}, author = {Yousef Ahmed Alomi and Faiz Abdullah Bahadig} } @article {241, title = {Cardiovascular Medications Therapeutic Interchanges: A Narrative Reviews}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {9}, year = {2020}, month = {May 2020}, pages = {51-58}, type = {Review Article }, chapter = {51}, abstract = {

Objective: To review the cardiovascular medications therapeutic interchanges. Methods: It is an extensive search, or fifty databases included the following through the Saudi Digital Library (SDL) searching engine. It included the various types of studies (meta-analysis, randomized controlled studies and observational studies) in the English language with human study only for the update May 2017. The search in terms of therapeutic interchange, medication, therapy, type of disease or medication base on therapeutics class of anti-psychiatric. The medication list and switch from one drug to alternative based on the literature found the search that has included comparative safety, efficacy and cost of the type of medication for each disease and national or international evidence-based guidelines. Results: The total number of studies after an extensive search with a specific term search was 487 studies. Of those, there were 107 duplicated studies, and 380 studies included for future evaluation. After evaluation, there were 64 studies about therapeutic interchange of cardiovascular medications. Conclusion: The cardiovascular therapeutic interchange studies are wide-ranging and common available findings in the literature. Most of the studies have observational non-randomized. Comparative studies published in management guidelines as an alternative interchange of this matter. Cardiovascular therapeutic interchanges are highly recommended for execution in the Kingdom of Saudi Arabia.

}, keywords = {Cardiovascular, Drug, Literature, Review, Therapeutic interchanges, Therapy}, doi = {10.5530/ijpcs.2020.9.10}, author = {Yousef Ahmed Alomi and Faiz Abdullah Bahadig} }